Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Psychiatric Clinical Pearls for Pharmacists
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA & NSAID use on the rise
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone Journal of Acquired Immune Deficiency Syndromes, June 18, 2013 Clinical Article
2 Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID) Diagnostic Microbiology and Infectious Disease, June 18, 2013 Clinical Article
3 Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus Diagnostic Microbiology and Infectious Disease, June 18, 2013 Clinical Article
4 Echinocandin and triazole antifungal susceptibility profiles of opportunistic yeast and mould clinical isolates (2010-2011): Application of new CLSI clinical breakpoints and epidemiological cutoff values to characterize geographic and temporal trends of antifungal resistance Journal of Clinical Microbiology, June 18, 2013 Clinical Article
5 Methicillin-resistant Staphylococcus aureus carrying SCCmec type II was more frequent than the Brazilian endemic clone as a cause of nosocomial bacteremia Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
6 Susceptibility of enterococci to daptomycin is dependent upon testing methodology Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
7 Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance Scandinavian Journal of Infectious Diseases, June 18, 2013 Clinical Article
8 Prevalence of Ambler class A β-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii Diagnostic Microbiology and Infectious Disease, June 18, 2013 Review Article
9 Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones Diagnostic Microbiology and Infectious Disease, June 18, 2013 Clinical Article
10 Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumanniicalcoaceticus complex Scandinavian Journal of Infectious Diseases, June 18, 2013 Clinical Article
11 Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review Scandinavian Journal of Infectious Diseases, June 18, 2013 Review Article
12 Comparison of pyrosequencing, Sanger sequencing and melting curve analysis for detection of low frequency macrolide-resistant Mycoplasma pneumoniae quasispecies in respiratory specimens Journal of Clinical Microbiology, June 18, 2013 Review Article
13 Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial Scandinavian Journal of Infectious Diseases, June 18, 2013 Clinical Article
14 Cutaneous leishmaniasis in a patient receiving infliximab Scandinavian Journal of Infectious Diseases, June 18, 2013 Clinical Article
15 Emerging moxifloxacin resistance in pseudomonas aeruginosa keratitis isolates in South India Ophthalmic Epidemiology, June 18, 2013 Clinical Article
16 When to start antiretroviral therapy: as soon as possible Full Text BMC Medicine, June 17, 2013
17 When to start antiretroviral therapy: The need for an evidence base during early HIV infection Full Text BMC Medicine, June 17, 2013 Clinical Article
18 Acute cough: The use of antibiotics and health care services in an urban health centre in Israel European Journal of General Practice, June 17, 2013 Review Article
19 Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a Novel HIV NRTI, in treatment-experienced HIV-1–infected subjects Journal of Acquired Immune Deficiency Syndromes, June 17, 2013 Clinical Article
20 Mass treatment with azithromycin for trachoma: When is one round enough? Results from the PRET trial in the Gambia Full Text PLoS Neglected Tropical Diseases, June 17, 2013 Clinical Article
1 Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections Clinical Infectious Diseases, May 24, 2013
2 Are We Ready for an Outpatient Parenteral Antimicrobial Therapy Bundle? A Critical Appraisal of the Evidence Clinical Infectious Diseases, May 8, 2013
3 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections Cochrane Reviews, March 29, 2013 Review Article
4 Interventions to improve antibiotic prescribing practices for hospital inpatients Cochrane Reviews, May 16, 2013 Evidence Based Medicine
5 Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion International Journal of Antimicrobial Agents, May 3, 2013
6 Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update Expert Review of Anti-infective Therapy, May 7, 2013
7 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Clinical Infectious Diseases, April 1, 2013
8 Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone Infection, May 20, 2013
9 Antibiotic Therapy: Adverse Effects and Dosing Considerations U.S. Pharmacist, May 1, 2013 Free full text
10 A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population Indian Journal of Dermatology, Venereology and Leprology , May 10, 2013 Free full text
11 Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection European Journal of Clinical Pharmacology, April 3, 2013
12 Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin Outcomes Registry and Experience International Journal of Antimicrobial Agents, May 6, 2013
13 Understanding the Determinants of Antimicrobial Prescribing within hospitals: The role of Prescribing Etiquette Clinical Infectious Diseases, May 1, 2013 Review Article
14 Time to Initiation of Antifungal Therapy for Neonatal Candidiasis Antimicrobial Agents and Chemotherapy, May 17, 2013
15 Reducing the costs of paediatric antibiotic prescribing in the community by implementing guideline recommendations Journal of Clinical Pharmacy and Therapeutics, April 30, 2013 Clinical Guideline
16 Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, April 23, 2013
17 An Evaluation of Vancomycin Susceptibility Testing For Methicillin-Resistant S. aureus: A comparison of Etest and three automated testing methods Journal of Clinical Microbiology, May 8, 2013
18 Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review Antiviral Therapy , May 21, 2013 Review Article
19 Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models European Journal of Clinical Microbiology & Infectious Diseases, May 10, 2013
20 Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species European Journal of Clinical Microbiology & Infectious Diseases, May 2, 2013
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close